Otilia Koo

1.2k total citations · 1 hit paper
16 papers, 882 citations indexed

About

Otilia Koo is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, Otilia Koo has authored 16 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 6 papers in Biomaterials and 5 papers in Molecular Biology. Recurrent topics in Otilia Koo's work include Drug Solubulity and Delivery Systems (8 papers), Nanoparticle-Based Drug Delivery (4 papers) and Analytical Methods in Pharmaceuticals (3 papers). Otilia Koo is often cited by papers focused on Drug Solubulity and Delivery Systems (8 papers), Nanoparticle-Based Drug Delivery (4 papers) and Analytical Methods in Pharmaceuticals (3 papers). Otilia Koo collaborates with scholars based in United States, Germany and Singapore. Otilia Koo's co-authors include Hayat Önyüksel, Israel Rubinstein, Eugene Khor, Lee Yong Lim, Paul Wan Sia Heng, Murat Kartal, Nilüfer Tarımcı, Sanjeev Kothari, Israel Rubinstein and Sailesh A. Varia and has published in prestigious journals such as Methods in enzymology on CD-ROM/Methods in enzymology, Journal of Hepatology and International Journal of Pharmaceutics.

In The Last Decade

Otilia Koo

16 papers receiving 839 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of nanotechnology in targeted drug delivery and imaging: a concise review

2005 506 citations Otilia Koo, Israel Rubinstein et al. Nanomedicine Nanotechnology Biology and Medicine profile →

Peers

Countries citing papers authored by Otilia Koo

Since Specialization

Citations

This map shows the geographic impact of Otilia Koo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Otilia Koo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otilia Koo more than expected).

Fields of papers citing papers by Otilia Koo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Otilia Koo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Otilia Koo. The network helps show where Otilia Koo may publish in the future.

Co-authorship network of co-authors of Otilia Koo

This figure shows the co-authorship network connecting the top 25 collaborators of Otilia Koo. A scholar is included among the top collaborators of Otilia Koo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Otilia Koo. Otilia Koo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Effect of hydroxy propyl cellulose grade and foam quality on foam granulation of a high drug load formulation 2024 ·International Journal of Pharmaceutics ·Otilia Koo, Chandrakant Patel, (unknown)	1
2	The Impact of Disintegrant Type, Surfactant, and API Properties on the Processability and Performance of Roller Compacted Formulations of Acetaminophen and Aspirin 2017 ·The AAPS Journal ·(unknown), Otilia Koo, Duohai Pan, Yongmei Wu, (unknown), (unknown), (unknown), (unknown)	20
3	Mitigation of Adverse Clinical Events of a Narrow Target Therapeutic Index Compound through Modified Release Formulation Design: An in Vitro, in Vivo, in Silico, and Clinical Pharmacokinetic Analysis 2015 ·Molecular Pharmaceutics ·David Good, (unknown), Neil Mathias, John R. Crison, Giridhar Tirucherai, Peter Timmins, Munir Hussain, (unknown), Otilia Koo, (unknown), (unknown)	9
4	P1156 DACLATASVIR, ASUNAPREVIR, AND BMS-791325 IN A FIXED-DOSE COMBINATION: A PHASE 1 BIOAVAILABILITY STUDY IN HEALTHY VOLUNTEERS 2014 ·Journal of Hepatology ·(unknown), Karen Sims, (unknown), (unknown), Janice Pursley, S.T. Charlton, Otilia Koo, Richard Bertz, Bhaskar Rege, Malaz Abutarif	1
5	Effect of Powder Substrate on Foam Drainage and Collapse: Implications to Foam Granulation 2012 ·Journal of Pharmaceutical Sciences ·Otilia Koo, (unknown), Jinjiang Li	10
6	Nanomedicines for Inflammatory Diseases 2012 ·Methods in enzymology on CD-ROM/Methods in enzymology ·(unknown), Otilia Koo, Hayat Önyüksel	16
7	Investigation into Stability of Poly(Vinyl Alcohol)-Based Opadry® II Films 2011 ·AAPS PharmSciTech ·Otilia Koo, (unknown), Haitao Yang, (unknown), Ajit B. Thakur, (unknown), (unknown)	9
8	Case Studies With New Excipients: development, Implementation and Regulatory Approval 2011 ·Therapeutic Delivery ·Otilia Koo, Sailesh A. Varia	12
9	Evaluation of the physical and mechanical properties of high drug load formulations: Wet granulation vs. novel foam granulation 2009 ·Powder Technology ·(unknown), Sanjeev Kothari, Otilia Koo	28
10	Use of cyclodextrins as a cosmetic delivery system for fragrance materials: Linalool and benzyl acetate 2007 ·AAPS PharmSciTech ·(unknown), (unknown), Nilüfer Tarımcı, Murat Kartal, Otilia Koo, Hayat Önyüksel	57
11	Camptothecin in Sterically Stabilized Phospholipid Nano-Micelles: A Novel Solvent pH Change Solubilization Method 2006 ·Journal of Nanoscience and Nanotechnology ·Otilia Koo, Israel Rubinstein, Hayat Önyüksel	19
12	Camptothecin in sterically stabilized phospholipid micelles: A novel nanomedicine 2005 ·Nanomedicine Nanotechnology Biology and Medicine ·Otilia Koo, Israel Rubinstein, Hayat Önyüksel	80
13	Role of nanotechnology in targeted drug delivery and imaging: a concise review breakdown → 2005 ·Nanomedicine Nanotechnology Biology and Medicine ·Otilia Koo, Israel Rubinstein, Hayat Önyüksel	506
14	A Study of the Effects of the Physical Characteristics of Microcrystalline Cellulose on Performance in Extrusion Spheronization 2001 ·Pharmaceutical Research ·Paul Wan Sia Heng, Otilia Koo	31
15	? Irradiation of chitosan 1998 ·Journal of Biomedical Materials Research ·Lee Yong Lim, Eugene Khor, Otilia Koo	82
16	γ Irradiation of chitosan 1998 ·Journal of Biomedical Materials Research ·Lee Yong Lim, Eugene Khor, Otilia Koo	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact